AstraZeneca's facility in Speke, UK (Image: AstraZeneca)

As­traZeneca al­lo­cates £650M to boost its UK man­u­fac­tur­ing, cam­pus foot­print 

As­traZeneca is look­ing to spend £450 mil­lion ($827.1 mil­lion) to ex­pand its UK vac­cine man­u­fac­tur­ing site, on top of a £200 bud­get ($254.4 mil­lion) on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.